Drug-induced pulmonary infection Journal Article


Author: White, D. A.
Article Title: Drug-induced pulmonary infection
Abstract: Immunosuppressive drugs lead to an enhanced risk for infection. The impact of these drugs on the immune system can be broad (eg, corticosteroids) or targeted (eg, rituximab). Infections can have serious consequences, particularly if there is a delay in diagnosis. It is hoped that a knowledge of the type of immune defects that are induced by these drugs and the specific infections that have been reported will guide clinicians in the appropriate use of prophylactic regimens and diagnostic considerations in the event of pneumonia.
Keywords: antibiotic agent; fludarabine; prednisone; review; methotrexate; rituximab; chemoprophylaxis; immunoglobulin; pneumocystis pneumonia; antiinfective agent; mycobacterium tuberculosis; tumor necrosis factor-alpha; etanercept; glucocorticoid; purine derivative; corticosteroid; immunosuppressive treatment; tacrolimus; lung infection; ganciclovir; cytomegalovirus infection; cyclosporin; cyclosporine; immunosuppressive agents; voriconazole; cytomegalovirus; infection risk; aspergillosis; lung aspergillosis; alemtuzumab; listeriosis; listeria monocytogenes; pentostatin; legionella; tuberculosis; bronchitis; opportunistic infection; itraconazole; cladribine; glucocorticoids; histoplasmosis; lung diseases; lung tuberculosis; communicable diseases; bacterial pneumonia; infliximab; pneumocystis carinii; purine nucleosides; pneumonia, pneumocystis; humans; human; priority journal; nocardia; nocardiosis
Journal Title: Clinics in Chest Medicine
Volume: 25
Issue: 1
ISSN: 0272-5231
Publisher: Elsevier Inc.  
Date Published: 2004-03-01
Start Page: 179
End Page: 187
Language: English
DOI: 10.1016/s0272-5231(03)00134-5
PROVIDER: scopus
PUBMED: 15062609
DOI/URL:
Notes: Clin. Chest Med. -- Cited By (since 1996):22 -- Export Date: 16 June 2014 -- CODEN: CCHMD -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dorothy A White
    74 White